Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study
- PMID: 34105510
- PMCID: PMC8215568
- DOI: 10.3310/hta25370
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study
Abstract
Background: Many decisions in health care aim to maximise health, requiring judgements about interventions that may have higher health effects but potentially incur additional costs (cost-effectiveness framework). The evidence used to establish cost-effectiveness is typically uncertain and it is important that this uncertainty is characterised. In situations in which evidence is uncertain, the experience of experts is essential. The process by which the beliefs of experts can be formally collected in a quantitative manner is structured expert elicitation. There is heterogeneity in the existing methodology used in health-care decision-making. A number of guidelines are available for structured expert elicitation; however, it is not clear if any of these are appropriate for health-care decision-making.
Objectives: The overall aim was to establish a protocol for structured expert elicitation to inform health-care decision-making. The objectives are to (1) provide clarity on methods for collecting and using experts' judgements, (2) consider when alternative methodology may be required in particular contexts, (3) establish preferred approaches for elicitation on a range of parameters, (4) determine which elicitation methods allow experts to express uncertainty and (5) determine the usefulness of the reference protocol developed.
Methods: A mixed-methods approach was used: systemic review, targeted searches, experimental work and narrative synthesis. A review of the existing guidelines for structured expert elicitation was conducted. This identified the approaches used in existing guidelines (the 'choices') and determined if dominant approaches exist. Targeted review searches were conducted for selection of experts, level of elicitation, fitting and aggregation, assessing accuracy of judgements and heuristics and biases. To sift through the available choices, a set of principles that underpin the use of structured expert elicitation in health-care decision-making was defined using evidence generated from the targeted searches, quantities to elicit experimental evidence and consideration of constraints in health-care decision-making. These principles, including fitness for purpose and reflecting individual expert uncertainty, were applied to the set of choices to establish a reference protocol. An applied evaluation of the developed reference protocol was also undertaken.
Results: For many elements of structured expert elicitation, there was a lack of consistency across the existing guidelines. In almost all choices, there was a lack of empirical evidence supporting recommendations, and in some circumstances the principles are unable to provide sufficient justification for discounting particular choices. It is possible to define reference methods for health technology assessment. These include a focus on gathering experts with substantive skills, eliciting observable quantities and individual elicitation of beliefs. Additional considerations are required for decision-makers outside health technology assessment, for example at a local level, or for early technologies. Access to experts may be limited and in some circumstances group discussion may be needed to generate a distribution.
Limitations: The major limitation of the work conducted here lies not in the methods employed in the current work but in the evidence available from the wider literature relating to how appropriate particular methodological choices are.
Conclusions: The reference protocol is flexible in many choices. This may be a useful characteristic, as it is possible to apply this reference protocol across different settings. Further applied studies, which use the choices specified in this reference protocol, are required.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 37. See the NIHR Journals Library website for further project information. This work was also funded by the Medical Research Council (reference MR/N028511/1).
Keywords: DECISION-MAKING; EXPERT ELICITATION; HEALTH; TRANSPARENCY; UNCERTAINTY.
Plain language summary
Background: Decisions in health care aim to maximise health, requiring judgements about treatments. The evidence used to make these judgements is typically uncertain. In these situations, the experience of experts is essential. Structured expert elicitation collects beliefs from experts. There are different guidelines available for structured expert elicitation; however, it is not clear if any of these be can be used in health-care decision-making, for example in considering if a treatment should be made available in the NHS. This project aimed to develop a guidance for structured expert elicitation to inform health-care decision-making.
Methods: Reviews and experimental techniques were used to gather a list of methods to conduct structured expert elicitation. The suitability of these choices in health-care decision-making was then determined by comparing these with a set of standards that support the use of structured expert elicitation in health-care decision-making.
Results: Different guidelines prefer different approaches to conduct structured expert elicitation. There is a lack of evidence available to determine which of these methods is most appropriate across the whole of health-care decision-making. It is possible to define reference protocol methods that could be used in a particular type of health-care decision-making, health technology assessment. This includes gathering experts with knowledge of the clinical area, asking experts about things that they observe in clinical practice and asking experts individually for their beliefs. For decision-makers working outside health technology assessment, for example at a local level, or for treatments that are not yet available to patients, these choices may not be appropriate.
Conclusions: This flexibility of this guidance is a useful feature. It is possible for different decision-makers in health care to interpret the reference protocol for their own circumstances.
Similar articles
-
Reference Case Methods for Expert Elicitation in Health Care Decision Making.Med Decis Making. 2022 Feb;42(2):182-193. doi: 10.1177/0272989X211028236. Epub 2021 Jul 16. Med Decis Making. 2022. PMID: 34271832 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.Health Technol Assess. 2021 Dec;25(76):1-228. doi: 10.3310/hta25760. Health Technol Assess. 2021. PMID: 34990339
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
Cited by
-
Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP".Int J Technol Assess Health Care. 2023 Oct 12;39(1):e70. doi: 10.1017/S026646232300260X. Int J Technol Assess Health Care. 2023. PMID: 37822085 Free PMC article. No abstract available.
-
Psychometric properties of comprehensive cognitive, affective, and psychomotor competency assessment scales in psychodynamic psychotherapy for borderline personality disorder.Front Psychiatry. 2024 Dec 6;15:1389992. doi: 10.3389/fpsyt.2024.1389992. eCollection 2024. Front Psychiatry. 2024. PMID: 39713768 Free PMC article.
-
Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups.Pharm Stat. 2025 Mar-Apr;24(2):e2456. doi: 10.1002/pst.2456. Epub 2024 Nov 25. Pharm Stat. 2025. PMID: 39587432 Free PMC article.
-
Using Expert Elicitation to Adjust Published Intervention Effects to Reflect the Local Context.MDM Policy Pract. 2024 Jan 25;9(1):23814683231226335. doi: 10.1177/23814683231226335. eCollection 2024 Jan-Jun. MDM Policy Pract. 2024. PMID: 38283395 Free PMC article.
-
Internal communication from a happiness management perspective: state-of-the-art and theoretical construction of a guide for its development.BMC Psychol. 2024 Nov 9;12(1):644. doi: 10.1186/s40359-024-02140-7. BMC Psychol. 2024. PMID: 39522021 Free PMC article.
References
-
- Bryan S, Williams I, McIver S. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Econ 2007;16:179–93. https://doi.org/10.1002/hec.1133 doi: 10.1002/hec.1133. - DOI - PubMed
-
- Bothwell LE, Greene JA, Podolsky SH, Jones DS. Assessing the gold standard – lessons from the history of RCTs. N Engl J Med 2016;374:2175–81. https://doi.org/10.1056/NEJMms1604593 doi: 10.1056/NEJMms1604593. - DOI - PubMed
-
- Chavez-MacGregor M, Giordano SH. Randomized clinical trials and observational studies: is there a battle? J Clin Oncol 2016;34:772–3. https://doi.org/10.1200/jco.2015.64.7487 doi: 10.1200/jco.2015.64.7487. - DOI - PubMed
-
- Rothwell PM. External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’. Lancet 2005;365:82–93. https://doi.org/10.1016/S0140-6736(04)17670-8 doi: 10.1016/S0140-6736(04)17670-8. - DOI - PubMed
-
- Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med 2017;377:465–75. https://doi.org/10.1056/NEJMra1614394 doi: 10.1056/NEJMra1614394. - DOI - PubMed